Dosing regimens for neural stem cell proliferating agents and differentiating agents for the treatment of neurological disorders
US8143220B2 · kind B2 · utility
5Cited by
66References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 16, 2007 |
| Grant date | Mar 27, 2012 |
| Priority date | — |
| Expiry date | Mar 16, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Effective dosing regimens for neural stem cell proliferating and differentiating agents, kits comprising effective dosing regimens for neural stem cell proliferating and differentiating agents, and uses thereof are provided herein. Such kits and methods can be utilized acutely or chronically to treat a neurodegenerative disease or condition. Furthermore, the compositions and methods can be used continuously or intermittently in various dosing regimens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.